Editorial: Ubiquitin-Modifying Enzymes as Drug Targets and Biomarkers in Cancer

Affiliations

• ¹ Children's Cancer Institute, School of Women's and Children's Health, Lowy Cancer Centre, University of New South Wales (UNSW), Sydney, NSW, Australia.
• ² Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.
• ³ Institute of Molecular Medicine, Faculty of Medicine, Martin-Luther University of Halle-Wittenberg, Halle, Germany.
• ⁴ Department of Radiation Oncology, Arthur G James Comprehensive Cancer Center and Richard L. Solove Research Institute, The Ohio State University, Columbus, OH, United States.
• ⁵ Cancer Institute, The Second Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.